RxDoctor Payments Data

Caille Roy

Family · Newmarket, NHNPI 1033629068

Payments from drug & device makers

$268in general payments, 2019–2025

Across 5 payments — averaging $53.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$94
  • Boehringer Ingelheim$64
  • AbbVie$61
  • Novo Nordisk$50

What the payments were for

  • Food & beverage$268100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$94
Boehringer Ingelheim1$64
AbbVie2$61
Novo Nordisk1$50

How this compares

$268 in reported general payments places this provider in the 60th percentile of 713 family providers in New Hampshire.

See all family providers in New Hampshire

Medicare billing

Part B allowed, 2024
$787,940
Medicare patients
581
Services billed
14,857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate12$460
Pantoprazole Sodium43$408
Atorvastatin Calcium33$115
Tramadol Hcl18$36

Paid to pharmacies, not to this prescriber.

Other family in Newmarket

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →